Investors Face September Deadline in GPGI Securities Fraud Lawsuit
Investors who purchased Class A common stock of GPGI, Inc.—formerly CompoSecure—between November 2025 and May 2026 have until September 14, 2026, to file as lead plaintiffs. A class action lawsuit alleges the company misled shareholders regarding the financial health and underlying motives of its Husky acquisition.

The lawsuit, filed by the Rosen Law Firm, claims that GPGI executives issued materially false statements throughout the class period. According to the complaint, the company allegedly overstated the value of Husky while failing to disclose that the subsidiary was failing to meet revenue and Adjusted EBITDA targets. Furthermore, the suit suggests the acquisition was primarily orchestrated to generate fees for Resolute Holdings and individual defendants rather than to provide long-term value for shareholders.
Those who purchased stock during this window are not automatically represented by counsel until a class is formally certified. Investors seeking to participate as a lead plaintiff must move the court before the September deadline. While Rosen Law is soliciting participants for the existing litigation, investors retain the right to select their own counsel or remain absent class members, as the ability to share in a potential future recovery does not strictly require serving as a lead representative.
Comments (0)
No comments yet. Be the first!